Staphylococcus Aureus Bacteremia
📧 Sign up to get email alerts when something new happens for Staphylococcus Aureus Bacteremia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-09-19FDA Approved: DAPTOMYCIN — Supplemental Application (Sagent Pharmaceuticals)
The FDA approved a supplemental application for daptomycin filed by Sagent Pharmaceuticals (ANDA 207104), resulting in an approved regulator…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia [Phase 3]
A Phase 3 trial evaluating ceftobiprole for Staphylococcus aureus bacteremia has completed, with results posted in 2023.
-
FDA approval · 2022-11-13FDA Approved: DAPTOMYCIN — Supplemental Application (APOTEX CORP.)
FDA approved a supplemental application for Daptomycin from Apotex Corp. (ANDA 215316).
-
CLINICAL_TRIALS withdrawal · 2022-04-06Clinical Trial Update: Oritavancin for Staphylococcus Aureus Infections in Opioid Users [Phase 4]
Phase 4 trial of oritavancin for Staphylococcus aureus infections in opioid users has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia [Phase 2]
Phase 2 trial evaluating CF-301 (oritavancin-like agent) added to antibacterial therapy for Staphylococcus aureus bacteremia and endocarditi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-08-24FDA Approved: DAPTOMYCIN — Original Application (APOTEX CORP.)
FDA approved Apotex's Original Application for a generic version of daptomycin. The product is indicated for complicated skin and skin struc…
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: Phase IIa Clinical Study of N-Rephasin® SAL200 [Phase 2]
Phase IIa trial of N-Rephasin SAL200 was terminated; results posted in 2021 for Staphylococcus aureus bacteremia treatment.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Seven Versus Fourteen Days of Treatment in Uncomplicated Staphylococcus Aureus Bacteremia [Phase 4]
A Phase 4 trial update comparing seven versus fourteen days of treatment for uncomplicated Staphylococcus aureus bacteremia.
-
CLINICAL_TRIALS trial_result · 2020-09-22Clinical Trial Update: Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia [Phase 4]
Phase 4 clinical trial evaluating daptomycin as adjunctive therapy for methicillin-susceptible Staphylococcus aureus bacteremia has complete…
-
FDA approval · 2020-08-20FDA Approved: DAPTOMYCIN — Original Application (BE Pharmaceuticals Inc.)
The FDA approved BE Pharmaceuticals Inc.'s Original Application for Daptomycin (DAPTOMYCIN) as a generic antibiotic. The approval enables ge…
-
FDA label_change · 2020-04-03FDA Approved: DAPTOMYCIN — Supplemental Application (Sagent Pharmaceuticals)
FDA notice of a supplemental application for Daptomycin submitted by Sagent Pharmaceuticals, with the submission status shown as AP.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial [Phase 3]
Phase 3 trial evaluating telavancin for Staphylococcus aureus bacteremia was terminated; results posted in 2020.
-
FDA approval · 2019-11-15FDA Approved: DAPTOMYCIN — Original Application (Sagent Pharmaceuticals)
FDA approved the original application for daptomycin by Sagent Pharmaceuticals, authorizing a generic injectable form of daptomycin.
-
FDA approval · 2019-08-22FDA Approved: DAPTOMYCIN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s generic daptomycin under an Original Application. The approval covers the same indications as …
-
FDA approval · 2017-09-12FDA Approved: DAPTOMYCIN — Original Application (Sagent Pharmaceuticals)
FDA approval record for Daptomycin under an Original Application by Sagent Pharmaceuticals (NDA 208385). The entry documents FDA approval of…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 - 17 Year Olds With Staphylococcus Aureus Bacteremia (MK-3009-005) [Phase 4]
Phase 4 trial comparing daptomycin to standard of care in pediatric patients (1-17 years) with Staphylococcus aureus bacteremia; study compl…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Direct Thrombin Inhibitors Versus LMWH in Staphylococcus Aureus Bacteraemia [Phase 2]
Phase 2 trial comparing direct thrombin inhibitors to low molecular weight heparin in patients with Staphylococcus aureus bacteremia has com…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia [Phase 2]
Phase 2 randomized trial comparing vancomycin with daptomycin for Staphylococcus aureus bacteremia has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-08-07Clinical Trial Update: Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus. [Phase 3]
Phase 3 trial evaluating short-term sequential therapy for non-complicated catheter-related bloodstream infection due to methicillin-suscept…
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Staphylococcus Aureus Bacteremia: Impact of an Intervention Program in Improving the Clinical Management and Review of the Clinical and Molecular Epidemiology
This clinical trial update describes an intervention program aimed at improving clinical management and the molecular epidemiology review of…
-
CLINICAL_TRIALS other · 2014-12-03Clinical Trial Update: Staphylococcus Aureus Bacteraemia in Adults
Clinical trial update concerning Staphylococcus aureus bacteremia in adults; the current status of the study is not provided.
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia [Phase 4]
Phase 4 safety and efficacy study of ceftaroline for Staphylococcus aureus bacteremia and MRSA bacteremia has completed.
-
CLINICAL_TRIALS research · 2014-01-07Clinical Trial Update: Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia [NA]
Clinical trial update describing a study on early infectious disease consultations for patients with Staphylococcus aureus bacteremia.
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB) [Phase 2]
A completed Phase 2 trial compared safety and pharmacokinetics of standard antibiotic therapy plus Aurexis versus placebo in Staphylococcus …
-
CLINICAL_TRIALS withdrawal · 2013-02-20Clinical Trial Update: Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia [Phase 2]
A Phase 2 trial of ceftobiprole for hospitalized patients with Staphylococcus aureus bacteremia was withdrawn.